HIV / AIDS
Sep 17, 2024
A Phase 2, open-label, multicenter, randomized study to evaluate the pharmacokinetics, safety, and acceptability of twice-yearly long-acting subcutaneous lenacapavir for pre-exposure prophylaxis in cisgender women in the United...
Sep 17, 2024
A Phase 2, open-label, multicenter, randomized study to evaluate the pharmacokinetics, safety, and acceptability of twice-yearly long-acting subcutaneous lenacapavir for pre-exposure prophylaxis in cisgender women in the United...
Mar 26, 2024
ICAP is providing technical assistance to enhance laboratory systems through the implementation of laboratory quality management systems and accreditation; external quality assessment through proficiency testing of all laboratory testing areas; capacity building of...
Mar 26, 2024
ICAP is providing support to the Government of the Kingdom of Eswatini to implement HIV-1 Recent Infection Surveillance (EHRIS) among persons newly diagnosed with HIV Infection in Eswatini; strengthen disease surveillance systems; increase the capacity of Ministry of...
Mar 26, 2024
A multisite, open-label, randomized crossover study comparing adherence to a single daily dual prevention pill (DPP) versus FTC/TDF and Combined Oral Contraception separate pill dosing (2PR), given for pre-exposure prophylaxis and pregnancy prevention in people of...